A HER3-targeting antibody-drug conjugate for leptomeningeal metastasis
Nat Med
.
2025 Aug;31(8):2494-2495.
doi: 10.1038/s41591-025-03853-x.
Authors
Carey K Anders
1
,
Rani Bansal
2
,
Amanda E D Van Swearingen
2
Affiliations
1
Division of Medical Oncology, Duke Center for Brain and Spine Metastasis, Duke Cancer Institute, Durham, NC, USA. carey.anders@duke.edu.
2
Division of Medical Oncology, Duke Center for Brain and Spine Metastasis, Duke Cancer Institute, Durham, NC, USA.
PMID:
40745403
DOI:
10.1038/s41591-025-03853-x
No abstract available